Glancy Prongay & Murray LLP (GPM) reminds investors of the November 13, 2018 deadline to file a lead plaintiff motion in the class action filed on behalf of investors that purchased OPKO Health, Inc. (Opko or the Company) (NASDAQ: OPK) securities between September 26, 2013 and September 7, 2018, inclusive (the Class Period). Opko investors have until November 13, 2018 to file a lead plaintiff motion.
If you are a shareholder who suffered a loss, click here to participate.
On September 7, 2018, the U.S. Securities and Exchange Commission (SEC) filed a lawsuit against Opko and its CEO and Chairman Phillip Frost, alleging that Opko and Frost engaged in pump-and-dump schemes. On this news, Opkos share price fell $1.01 per share, or more than 18%, to close at $4.58 on September 7, 2018, thereby injuring investors.
The complaint filed in this class action alleges that defendants made false and/or misleading statements and/or failed to disclose that: (1) Opko and its Chairman and Chief Executive Officer, Phillip Frost, were engaged in a pump-and-dump scheme with several other individuals and companies in their investments in several penny stocks; (2) this illicit scheme would result in governmental scrutiny including from the SEC; and (3) as a result, defendants statements about Opkos business, operations and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Follow us for updates on Twitter: twitter.com/GPM_LLP.
If you purchased shares of OPKO, you may move the Court no later than November 13, 2018 to ask the Court to appoint you as lead plaintiff. To be a member of the Class you need not take any action at this time; you may retain counsel of your choice or take no action and remain an absent member of the Class. If you wish to learn more about this action, or if you have any questions concerning this announcement or your rights or interests with respect to these matters, please contact Lesley Portnoy, Esquire, of GPM, 1925 Century Park East, Suite 2100, Los Angeles California 90067 at 310-201-9150, Toll-Free at 888-773-9224, by email to [email protected], or visit our website at www.glancylaw.com. If you inquire by email please include your mailing address, telephone number and number of shares purchased.
This press release may be considered Attorney Advertising in some jurisdictions under the applicable law and ethical rules.